1ITU
HUMAN RENAL DIPEPTIDASE COMPLEXED WITH CILASTATIN
Summary for 1ITU
Entry DOI | 10.2210/pdb1itu/pdb |
Related | 1ITQ |
Descriptor | RENAL DIPEPTIDASE, 2-acetamido-2-deoxy-beta-D-glucopyranose, ZINC ION, ... (5 entities in total) |
Functional Keywords | dipeptidase, glycoprotein, membrane-bound, zinc protease beta-lactamase, cilastatin, complex (hydrolase-inhibitor), hydrolase |
Biological source | Homo sapiens (human) |
Total number of polymer chains | 2 |
Total formula weight | 84079.76 |
Authors | Nitanai, Y.,Satow, Y.,Adachi, H.,Tsujimoto, M. (deposition date: 2002-02-03, release date: 2002-08-28, Last modification date: 2024-11-13) |
Primary citation | Nitanai, Y.,Satow, Y.,Adachi, H.,Tsujimoto, M. Crystal Structure of Human Renal Dipeptidase Involved in beta-Lactam Hydrolysis J.Mol.Biol., 321:177-184, 2002 Cited by PubMed Abstract: Human renal dipeptidase is a membrane-bound glycoprotein hydrolyzing dipeptides and is involved in hydrolytic metabolism of penem and carbapenem beta-lactam antibiotics. The crystal structures of the saccharide-trimmed enzyme are determined as unliganded and inhibitor-liganded forms. They are informative for designing new antibiotics that are not hydrolyzed by this enzyme. The active site in each of the (alpha/beta)(8) barrel subunits of the homodimeric molecule is composed of binuclear zinc ions bridged by the Glu125 side-chain located at the bottom of the barrel, and it faces toward the microvillar membrane of a kidney tubule. A dipeptidyl moiety of the therapeutically used cilastatin inhibitor is fully accommodated in the active-site pocket, which is small enough for precise recognition of dipeptide substrates. The barrel and active-site architectures utilizing catalytic metal ions exhibit unexpected similarities to those of the murine adenosine deaminase and the catalytic domain of the bacterial urease. PubMed: 12144777DOI: 10.1016/S0022-2836(02)00632-0 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2 Å) |
Structure validation
Download full validation report
